Sealbond Limited 13D and 13G filings for Dogwood Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-25 5:30 pm Purchase | 2025-11-21 | 13D | Dogwood Therapeutics, Inc. DWTX | Sealbond Limited | 24,664,971 83.000% | 24,453,588![]() (+11568.38%) | Filing |
| 2025-03-17 9:11 pm Unchanged | 2025-03-12 | 13D | Dogwood Therapeutics, Inc. DWTX | Sealbond Limited | 211,383 15.900% | 0 (Unchanged) | Filing |
| 2024-10-15 4:19 pm Purchase | 2024-10-07 | 13D | Dogwood Therapeutics, Inc. DWTX | Sealbond Limited | 211,383 15.900% | 211,383![]() (New Position) | Filing |
